Sangamo Therapeutics Inc (SGMO) — Capital Reinvestment Ratio
Sangamo Therapeutics Inc (SGMO) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow ($11.76 Million) in capital expenditures ($115.00K). See Sangamo Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sangamo Therapeutics Inc Capital Reinvestment Ratio (2017–2020)
This chart tracks Sangamo Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. Check cash flow reinvestment rate of Sangamo Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Capital Reinvestment Ratio for Sangamo Therapeutics Inc from 2017 to 2020. For live market cap and broader valuation context, see SGMO company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.09x | $169.88 Million | $14.71 Million | ▼ -92.5% |
| 2018 | 1.16x | $37.15 Million | $43.06 Million | ▲ +245.5% |
| 2017 | 0.34x | $11.18 Million | $3.75 Million | — |